Abivax Establishes an At-the-Market (ATM) Program on Nasdaq
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19,…
Rosen Law Firm Urges ASML Holding N.V. (NASDAQ: ASML) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces…
Procaps Receives Nasdaq Listing Determination;To Request Hearing and Further Stay Pending Hearing
November 15, 2024 18:15 ET | Source: Procaps Group, S.A. MIAMI and…
Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration
November 15, 2024 17:00 ET | Source: Eagle Pharmaceuticals, Inc. WOODCLIFF LAKE,…
Invizyne Technologies Begins Trading on NASDAQ
Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a…
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024
Monrovia, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a…
ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds…
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on…
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 19:04 ET | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Nov.…
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 18:32 ET | Source: LENSAR, Inc. ORLANDO, Fla., Nov.…